Global Clinical Trials

Executive Summary

Global Clinical Trials (GCT) is a full-service Contract Research Organization (CRO) established in 2001, with dual headquarters in Princeton, NJ, and London, UK. The company provides end-to-end clinical trial services spanning Phase I through IV, as well as post-marketing activities, to pharmaceutical, biotechnology, and medical device clients. GCT differentiates itself through a tailored, flexible approach, leveraging local expertise across the USA, Europe, and Asia to deliver efficient and cost-effective trials. With over two decades of experience and a global footprint, GCT is well-positioned to capture increasing demand for outsourced clinical development services, particularly in oncology and other therapeutic areas. The CRO market is growing due to rising R&D costs and the need for specialized trial management, and GCT's emphasis on customization and regional knowledge supports its competitive edge among mid-tier CROs.

Upcoming Catalysts (preview)

• Q4 2026Expansion into Asian and emerging markets to capture growing clinical trial demand70% success
• Q2 2026Strategic partnership with a top-20 pharma company for a large Phase III oncology trial60% success
• Q3 2026Adoption of decentralized clinical trial (DCT) technologies to enhance patient recruitment and retention80% success